JTA-004
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JTA-004, covering 2022-03-02 to 2022-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis [Phase 3]